TOWARDS A BETTER UNDERSTANDING OF FACTOR VIII INHIBITORS WITH THE THROMBIN GENERATION ASSAY.

被引：0
|
作者：
van Dievoet, Marie-Astrid [1 ]
Desmet, Sandrine [1 ]
Lambert, Catherine [1 ]
Van Damme, An [1 ]
Hermans, Cedric [1 ]
Eeckhoudt, Stephane [1 ]
机构：
[1] Clin Univ St Luc, Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2019年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [31] Use of a calibrated automated thrombin generation assay to quantify accurately factor VIII levels in severe and moderate haemophilia A
    Ninivaggi, M.
    Dargaud, Y.
    Hemker, C. H.
    Lindhout, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 729 - 729
  • [32] Utility of converted factor VIII activity by thrombin generation assay for evaluation of clotting function among hemophilia A carriers
    Nogami, Keiji
    Kawamura, Takeshi
    Shima, Midori
    Yada, Koji
    HAEMOPHILIA, 2018, 24 : 28 - 29
  • [33] Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive
    Waters, E. K.
    Hilden, I.
    Sorensen, B. B.
    Ezban, M.
    Holm, P. K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) : 2041 - 2052
  • [34] Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
    Negrier, Claude
    Oldenburg, Johannes
    Kenet, Gili
    Meeks, Shannon L.
    Bordet, Jean-Claude
    Muller, Jens
    Le Quellec, Sandra
    Turecek, Peter L.
    Tripkovic, Nikola
    Dargaud, Yesim
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (04)
  • [35] Evaluation of thrombin generation assay in factor XI deficiency
    Kasonga, Fiston
    Feugray, Guillaume
    Chamouni, Pierre
    Barbay, Virginie
    Fresel, Marielle
    Chretien, Marie Helene
    Brunel, Sabine
    Duchez, Veronique Le Cam
    Billoir, Paul
    CLINICA CHIMICA ACTA, 2021, 523 : 348 - 354
  • [36] Factor XII deficiency evaluated by thrombin generation assay
    Feugray, Guillaume
    Kasonga, Fiston
    Chamouni, Pierre
    Barbay, Virginie
    Fresel, Marielle
    Chretien, Marie Helene
    Brunel, Sabine
    Duchez, Eronique Le Cam
    Billoir, Paul
    CLINICAL BIOCHEMISTRY, 2022, 100 : 42 - 47
  • [37] Thrombin Generation Assay and by-Passing Therapies in Patients with Inhibitors
    Kavakli, Kaan
    Ay, Yilmaz
    Karapinar, Deniz Yilmaz
    Balkan, Can
    BLOOD, 2011, 118 (21) : 1428 - 1429
  • [38] Thrombin generation assay for optimizing haemophilia A therapy in patients with inhibitors
    Berntorp, E.
    Ekman, M.
    Astermark, J.
    HAEMOPHILIA, 2008, 14 : 47 - 47
  • [39] The potential value of thrombin generation assay in the diagnosis of FV inhibitors
    Desage, Stephanie
    Jousselme, Emilie
    Le Quellec, Sandra
    Lienhart, Anne
    Nougier, Christophe
    Dargaud, Yesim
    Jourdy, Yohann
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) : E117 - E120
  • [40] The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay
    Matsumoto, T
    Shima, M
    Takeyama, M
    Yoshida, K
    Tanaka, I
    Sakurai, Y
    Giles, AR
    Yoshioka, A
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) : 377 - 384
12345